IL6 and Alzheimer disease: In addition, proinflammatory cytokines (interleukin 1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α [TNF-α]) are markedly increased in patients with mild cognitive impairment and AD [3-6], suggesting that intrathecal inflammation precedes AD development.